Treatment of lysosomal storage disorders: Focus on the neuronal ceroid-lipofuscinoses

被引：1
作者：
Pierret, Chris [1 ]
Morrison, Jason A. [1 ]
Kirk, Mark D. [1 ]
机构：
[1] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA
来源：
ACTA NEUROBIOLOGIAE EXPERIMENTALIS | 2008年 / 68卷 / 03期
关键词：
lusosomal storage; neuronal ceroid-lipofuscinoses; enzyme replacement; stem cell; gene therapy; substrate reduction;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Recent advances in our understanding of lysosomal storage disorders (LSDs) may lead to new therapies to treat the neuronal ceroid-lipofuscinoses (NCLs). In this review, enzyme replacement therapy, gene therapy, cell-mediated therapy and pharmaceutical treatments arc considered across the LSDs and extended to therapies for the NCLs. It is likely that I combination of approaches will produce the most beneficial clinical outcome for treatment of pathologies displayed by the NCLs.
引用
收藏
页码：429 / 442
页数：14
相关论文
共 50 条
  • [41] A canine model for neuronal ceroid lipofuscinosis highlights the promise of gene therapy for lysosomal storage diseases
    Phillips, Jonathan E.
    Gomer, Richard H.
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4
  • [42] Therapy for Lysosomal Storage Disorders
    Beck, Michael
    IUBMB LIFE, 2010, 62 (01) : 33 - 40
  • [43] The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function
    Parvin, Shaho
    Rezazadeh, Maryam
    Hosseinzadeh, Hassan
    Moradi, Mohsen
    Shiva, Shadi
    Gharesouran, Jalal
    NEUROMOLECULAR MEDICINE, 2019, 21 (02) : 160 - 169
  • [44] The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function
    Shaho Parvin
    Maryam Rezazadeh
    Hassan Hosseinzadeh
    Mohsen Moradi
    Shadi Shiva
    Jalal Gharesouran
    NeuroMolecular Medicine, 2019, 21 : 160 - 169
  • [45] Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses
    Myllykangas, L
    Tyynelä, J
    Page-McCaw, A
    Rubin, GM
    Haltia, MJ
    Feany, MB
    NEUROBIOLOGY OF DISEASE, 2005, 19 (1-2) : 194 - 199
  • [46] Neuronal ceroid lipofuscinoses - A clinical and morphologicial study of 17 patients from southern Brazil
    Puga, ACS
    Jardim, LB
    Chimelli, L
    De Souza, CFM
    Clivati, M
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (3A) : 597 - 606
  • [47] Top-down and bottom-up propagation of disease in the neuronal ceroid lipofuscinoses
    Ostergaard, John R.
    Nelvagal, Hemanth R.
    Cooper, Jonathan D.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [48] Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher disease
    A. R. Sawkar
    W. D’Haeze
    J. W. Kelly
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1179 - 1192
  • [49] Therapeutic strategies to ameliorate lysosomal storage disorders - a focus on Gaucher disease
    Sawkar, A. R.
    D'Haeze, W.
    Kelly, J. W.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (10) : 1179 - 1192
  • [50] Altered amino acid levels in sera of a mouse model for juvenile neuronal ceroid Lipofuscinoses
    Pearce, DA
    McCall, K
    Chattopadhyay, S
    CLINICA CHIMICA ACTA, 2003, 332 (1-2) : 145 - 148
12345